Leonteq Securities’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Leonteq Securities's RARE Position: Q3 2026 in Review
Leonteq Securities increased its Ultragenyx Pharmaceutical (RARE) stake by 684% in Q3 2026, buying an estimated $47.9K and bringing the position to 2,288 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #844.
Leonteq Securities first reported a position in RARE in Q4 2020 and has held it in 19 quarters since. The position peaked at $436K in Q2 2025. 186 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Leonteq Securities held 2,288 shares of Ultragenyx Pharmaceutical worth $34.4K as of Q3 2026.
- Leonteq Securities bought 1,996 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $47.9K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #844 holding.
- Leonteq Securities first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and has held it in 19 quarters since.
- Leonteq Securities's Ultragenyx Pharmaceutical position peaked at $436K in Q2 2025.
- 186 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.